Stavanger University Hospital Inflammatory Bowel Disease Trial

Launched by HELSE STAVANGER HF · Mar 9, 2012

Keywords

ClinConnect Summary

The Stavanger University Hospital Inflammatory Bowel Disease Trial is a study designed to better understand how to manage patients who have just been diagnosed with Inflammatory Bowel Disease (IBD). This research is taking place in Norway and focuses on gathering information about the health outcomes of these patients. While the study does not test a specific treatment, it will collect data on important areas like immune responses, quality of life, and levels of fatigue.

To be eligible for this trial, participants must be newly diagnosed with IBD and be willing to follow the treatment plan provided. Unfortunately, those who have had IBD in the past or who cannot give consent will not be able to participate. If you or a family member joins the study, you can expect regular check-ins and assessments to help the researchers learn more about managing IBD effectively. This information could potentially lead to improved care for future patients with the same condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • newly diagnosed IBD
• Exclusion Criteria:
• • previous IBD with specific treatment within 10 year
• • inability to consent
• • inability to adhere to treatment protocol